Brian Pflug, Pharm.D. Email & Phone Number

Princeton, NJ, US

Cambridge, MA, US

• Reported to Head of Neuropsychiatry and served as key member of the U.S. medical neuropsychiatry (NP) team and the Medical Director Office. Supported development and implementation of U.S. medical strategy for company.
• Led yearly development of U.S. neuropsychiatry, MDD, and PDD medical action plan and subsequent tactics through cross-collaboration with U.S. medical affairs (evidence generation, publications, and scientific.
• Led yearly US scientific communication projects including vendor selection / management, project objectives, and content development
• Served as U.S. medical team subject matter expert for key functions and stakeholders on U.S. affiliate level, including scientific communications, commercial, market access, legal, compliance, epidemiology, and.
• Devised and implemented strategy for U.S.-relevant data generation, leading data generation projects to address identified medical or scientific data gaps. Collaborated with U.S. NP clinical experts as well as global.
• Designated as U.S. medical expert for collaborative research projects, overseeing commercial promotional materials and leading the medical omnichannel strategic initiative to deliver disease-specific education through.

Ingelheim Am Rhein, Rhineland-Palatinate, DE

• Reported to Head of US Medical Affairs CDMA: Jardiance and led collaborations with Clinical Operations including Investigator Initiated Studies (IIS), publications team, regulatory, compliance, legal, field medical.
• Provided medical/scientific advice by working closely with local functions on the full clinical trial life cycle. Reviewed, synthesized, and analyzed clinical trial data and translated data into actionable plans at the.
• Collaborated with teams on US feasibility assessments and provided feedback to the Global team to guide protocol development.
• Contributed to the development of the clinical trial protocol and associated documents.MEDICAL ACTION STRATEGY AND PLANNING
• Provided input into the therapeutic area strategy including participation in the Integrated Brand Plan
• Led product strategy for local Medical Advisory Board and Expert Panel meetings, Medical Grants, and Medical Publications.

Franklin Lakes, New Jersey, US

• Led 13-member team, reporting to Vice President Global Medical Affairs, Diabetes Care. Established and directed strategic global diabetes care vision, encompassing market access demands, brand viability, clinical.
• Contributed medical insights for potential therapeutic area expansion and served as a subject matter resource on design and interpretation of internal and external clinical programs, supporting existing and new insulin.
• Led National MSL organization with responsibilities for KOL relationship, presented health care provider (HCP) product information, and provided disease state educational training. Grew team from 2 to 10 medical.
• Ensured proper staffing of medical affairs department, maintaining readiness for current and future product launches by aligning HCP educational needs with evidence-generation priorities.
• Bridged alignment among medical affairs plans, studies, and input with cross-functional product development teams in directing diabetes care advanced leads and core medical device leads.
• Led medical affairs publication planning committee and evidence-generation oversight committee. Directed publication strategy for clinical studies, ensuring dissemination of key clinical data for external education.

Lead the Global Publications and Medical Information Departments. Member of the Legal Medical and Regulator group which approves all US sales and marketing pieces. Work drectly with our Clinical Trials department / R&D / Market access regarding input to clinical trial designs as well as HEOR data development.

Paris, France, FR

Paris, France, FR

• Leadership as Team Manager
• Provided leadership to advanced degreed medical field liaisons (up to 11 at one time)
• Maximized business impact by providing direct performance feedback and tracking improvement milestones
• Developed and implemented NE regional MSL vision and strategy and motivated the team to achieve the team vision by providing analytical, therapeutic, and overall strategic imperative guidance
• Significant contributor to improving medical field liaison resource allocation in NE and understand key business geographic areas throughout the United States
• Consistently developed award winning team members 6 out of 6 yearsLeadership without Direct Line Management

Paris, France, FR

Paris, France, FR

• Provided scientific support to medical personnel through educational efforts to foster the health and well being of patients.
• Therapeutic areas of responsibilities included diabetes, allergic rhinitis, rheumatoid arthritis, and osteoporosis.
• Scientific Field Based Manager Division Leader - Type 2 Diabetes Disease Management- Amaryl (glimeperide) Product Team

Lawrence Township, NJ, US

• Enhance the utilization of cardiovascular and diabetic treatment algorithms through medical education to physicians, pharmacists, and managed healthcare organizations
• Therapeutic areas of responsibilities included diabetes, hyperlipidemia, and acute coronary syndrome
• Scientific Presenter- Type 2 Diabetes Disease Management - Hyperlipidemia Disease Management- ACS Disease Management